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Abstract: A new trijugin-type limonoid, cipatrijugin G (1), together with the related known cipatrijugin A (2), were isolated from 
the aerial parts of Cipadessa cinerascens. The structure of the new compound was determined by extensive analysis of its  
spectroscopic data and by comparison of its NMR data with those reported in the literature. Compound 1 showed cytotoxicity 
against tumor cell line A549 with an IC50 value of 9.78 µM. This is the first report of a trijugin-type limonoid bearing a  
γ-hydroxybutenolide unit, in comparison to the common furan unit as ring E. 
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Introduction 
Plants belonging to family Meliaceae are an abundant 
source of limonoids, which are a structurally diverse group of 
natural products, with a highly complex polycyclic skeleton.1–4 
These unusual structural features have attracted great attention 
as a challenging target for total synthesis,5,6 bioactivity  
evaluation,7,8 and biosynthetic studies.9,10 The genus Cipadessa 
(Meliaceae) is composed of nine species of shrubs or small 
tress (up to 5 m tall). C. cinerascens (Pell.) Hand.-Mazz. is a 
medicinal plant widely distributed in the southwest of mainland
China. The leaves and roots of the plant have traditionally 
been used for the treatment of rheumatism, malaria, scalds, 
and skin itches.11 Previous phytochemical investigations of C. 
cinerascens led to the isolation of a series of limonoids, some 
of which showed various biological activities, including  
cytotoxicity, insecticidal, and trypanocidal activities.1,12 
In the course of our ongoing project searching for bioactive 
secondary metabolites from Chinese medicinal plants,13–17 with 
Cipadessa cinerascens was recently collected from Guangxi 
Zhuang Automomous Region, China. A chemical investigation 
of the aerial parts of the plant has resulted in the isolation of a 
new trijugin-type limonoid, named cipatrijugin G (1), together 
with a related known compound cipatrijugin A (2)18 (Figure 1). 
In this paper, we report the isolation and structure elucidation 
of the new compound 1. 
 
Results and Discussion 
The air-dried powdered aerial parts (2.5 kg) of C.  
cinerascens were extracted using MeOH at room temperature. 
The MeOH extract was partitioned between a CHCl3 and H2O 
phase. The CHCl3-soluble phase was separated using silica gel 
column to obtain twelve fractions, named A–L. Fraction I was 
repeatedly chromatographed over silica gel, and Sephadex  
LH-20 columns to isolate compounds 1 and 2. 
The known compound 2 was readily identified as  
cipatrijugin A by comparison of its spectroscopic data with 
those reported in the literature.18 Moreover, cipatrijugin G (1) 
was obtained as a white powder. The molecular formula, 
C31H38O13, was determined using HRESIMS from the quasi-
molecular ion peak at m/z 641.2205 [M + Na]+ (calcd 
641.2210), suggesting the presence of thirteen degrees of un-
saturation. The IR spectrum showed the absorptions indicative 
of hydroxyl (3442 cm–1) and ester (1742 cm–1) and unsaturated 
carbonyl (1686 cm–1) functionalities. The 1H and 13C NMR 
 
Figure 1.  Chemical structures of compounds 1 and 2 
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spectra of 1 (Table 1) exhibited resonances for two acetyl 
groups (δH 2.05, 6H; δC 20.7, 20.2, 170.3, 170.9), four  
quaternary methyl (δH 0.91, 1.08, 0.78, 1.05; δC 17.7, 19.1, 
27.2, 22.6), one carbomethoxy (δH 3.68; δC 52.6, 176.2), one 
exo-cyclic double bond (δH 5.50, 5.25; δC 115.8, 142.7), one 
ketonic carbonyl (δC 208.5), one ring-D lactone, one hemiactal 
group (δH 6.18, δC 96.1), and four further oxygen-bearing  
methines (δH 4.19, 5.15, 5.22, 6.48; δC 65.3, 73.7, 74.1, 78.4). 
The aforementioned spectroscopic features and comparison 
with co-occurring cipatrijugin A (2)18 strongly suggested that 1 
was a limonoid with trijugin-type skeleton. In fact, the 1H and 
13C NMR data of 1 are very similar to those of compound 2 in 
rings B, C, and D, and mainly differed from those of 2 for  
C-20, C-21, C-22 and C-23 in ring E by the presence of a  
γ-hydroxybutenolide unit (instead of a furan unit), as well as 
an additional acetoxyl group at C-2 in ring A. Although there 
is no detected HMBC correlation from H-2 to the acetyl  
carbonyl carbon in OAc-2, the location of acetoxyl group at  
C-2 in ring A can be deduced by the remarkable downfield 
shifts of H-2 (δ 5.22) and C-2 (δ 65.3), and 1H-1H COSY  
correlations of H-2 (5.22, t, J = 3.3 Hz)/H-1 (4.19, d, J = 3.3 
Hz), and H-2 (5.22, t, J = 3.3 Hz)/H-3 (5.15, d, J = 3.6 Hz). 
The γ-hydroxybutenolide unit for ring E could be confirmed 
by diagnostic HMBC correlations of H-21/C-22/C-23, and  
H-22/C-20/C-23. Furthermore, the 21-hydroxy-20(22)-ene-
21,23--lactone moiety was unambiguously secured by  
comparison of the 13C NMR data with those of the  
corresponding part of the model compound turrapubesin G, a 
natural product previously isolated from Turraea pubescens.19 
The HMBC correlations of H-22/C-17 and H-17/C-20 clearly 
indicated a linkage between rings D and E. Finally,  
comprehensive analysis of the 1H-1H COSY, HSQC, and 
HMBC spectra (Figure 2) allowed to assign all the chemical 
shifts in the 1H and 13C NMR spectra (Table 1) of 1. 
The relative configurations for ring junction centers of 1 
were suggested to be the same as those of co-occurring 2 
based on similar 1H and 13C NMR chemical shifts and  
biogenetic consideration. Further, the relative configurations 
for C-2 and C-17 were determined by ROESY experiment. 
Table 1. 1H and 13C NMR data for compounds 1a and 2b (J in Hz) 
 
position 
1  2 
δH δC δH δC 
1 4.19, d, (3.3) 73.7 (d)  4.16, t, (2.5) 71.6 
2 5.22, t, (3.3) 65.3 (d)  2.19, dt, (16.0, 2.5) 29.6 
2    1.91, dt, (16.0, 2.5)  
3 5.15, d, (3.6) 74.1 (d)  4.79, t, (2.5) 74.7 
4  39.3 (s)   38.3 
5 2.90, overlapped 37.8 (d)  2.98, t, (4.5) 37.9 
6 2.95, br. d, (4.2) 29.2 (t)  2.90, dd, (18.0, 4.5) 29.6 
6 2.25, br. d, (3.6)   2.27, dd, (18.0, 4.5)  
7  176.2 (s)   174.4 
8  142.7 (s)   144.5 
9  208.5 (s)   210.2 
10  56.0 (s)   55.2 
11 3.60, dd, (3.3, 9.3) 58.3 (d) 3.52, dd, (4.0, 10.0) 58.6
12 1.85, m 35.3 (t)  1.70, dd, (14.0, 10.0) 35.7 
12 2.80, overlapped   2.81, dd, (14.0, 4.0)  
13  45.5 (s)   46.0 
14  87.6 (s)   87.5 
15 2.88, overlapped 33.7 (t)  2.79, m 34.5 
15 2.80, overlapped   2.79, m  
16  167.5 (s)   170.7 
17 6.48, s 78.4 (d)  6.41, s 79.3 
18 0.91, s  17.7 (q)  0.78, s 17.5 
19 1.08, s 19.1 (q)  1.02, s 19.9 
20  164.1 (s)   121.9 
21 6.18, br. s 96.1 (d)  7.55, s 143.5 
22 6.31, s 119.9 (d)  6.46, br. s 108.6 
23  169.2 (s)  7.44, br. s 139.8 
28 0.78, s 27.2 (q)  0.87, s 27.5 
29 1.05, s 22.6 (q) 0.95, s 22.9
30 5.50, s  115.8 (t)  5.37, br. s 114.1 
30 5.25, s    5.17, br. s  
Ac-2 2.05, s 20.7 (q)    
  170.3 (s)    
Ac-3 2.05, s 20.2 (q)  2.04, s 20.8 
  170.9 (s)   168.8 
OCH3 3.68, s 52.6 (q)  3.66, s 51.7 
a1H NMR (CDCl3, 400 MHz); 13C NMR (CDCl3, 100 MHz); Chemical Shits (ppm) referred to CDCl3 (δH 7.26, δC 77.0,). 
b1H and 13C NMR data of 2 from ref. 18. 
 
Figure 2.  Selected 1H-1H COSY ( ), HMBC ( ), and 
ROESY ( ) correlations for 1 
C. S. JIANG et al.                                                                                                                    Nat. Prod. Bioprospect. 2013, 3, 267–270      269 
 
         
Thus, the relative configuration of C-2 was established by the 
clear NOE cross peak of H-2 (δH 5.22)/Me-19 (δH 1.08),  
suggesting the -orientation for acetoxyl group at C-2. The  
-orientation of H-17 was indicated by the NOE correlation of 
H-12 (δH 2.80)/H-17 (δH 6.48), consequently establishing the 
-orientation for γ-hydroxybutenolide ring at C-17. Thus, the 
relative structure of 1 was demonstrated as depicted in Figure 2. 
Compounds 1 and 2 were tested for in vitro cytotoxicity 
against tumor cell lines A549 and HL60. The results indicated 
that compound 1 showed strong cytotoxicity against A549 
with an IC50 value of 9.78 µM and no inhibition on HL60. 
Trijugin-type limonoids are of particular interest due to their 
complicated structures and promising activities. Since their 
first isolation in 1987,20 about 21 analogues had been reported 
to date according to the literature survey. However, to the best 
of our knowledge, cipatrijugin G (1) presents the first example 
of trijugin-type limonoids bearing a γ-hydroxybutenolide unit, 
instead of the common furan unit as ring E. The discovery of 1 
is an important addition to a diverse and complex array in the 
rapidly expanding class of known trijugin-type limonoids. 
Further studies should be conducted to prove the biosynthetic 
origin of these compounds and to understand their real  
ecological roles played in the life cycle of the plant, as well as 
to confirm their absolute configuration by total synthesis. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Perkin-Elmer 341 polarimeter. IR spectrum was 
recorded on a Nicolet Magna FT-IR 750 spectrometer. NMR 
spectra were measured on a Varian Mercury-400 spectrometer 
with the residual CDCl3 (δH 7.26 ppm; δC 77.01 ppm) as an 
internal standard. EIMS and HREIMS spectra were recorded 
on a Q-TOF Micro LC-MS mass spectrometer. All solvents 
were of analytical grade (Shanghai Chemical Plant, Shanghai, 
China). Commercial silica gel (Qing Dao Hai Yang Chemical 
Group Co., 200–300 and 400–600 mesh) was used for column 
chromatography, and precoated SiO2 gel plates (Yan Tai Zi Fu 
Chemical Group Co., G60 F-254) were used for analytical 
TLC. Sephadex LH-20 gel (Amersham Biosciences) was also 
used for column chromatography. 
 
Plant Material. The aerial parts of C. cinerascens were  
collected in Guangxi Zhuang Automomous Region, China, in 
July, 2008 and were identified by Jin-Gui Shen from Shanghai 
Institute of Material Medica. A voucher specimen is deposited 
at SIMM (voucher number JGL). 
 
Extraction and Isolation. The air-dried, powdered aerial 
parts of C. cinerascens (2.5 kg) were extracted by exhaustive 
maceration in MeOH (3  5 L, for one week) at room temp. 
The extracts were concentrated under reduced pressure to  
afford 297.7 g of dried residues, respectively. The MeOH  
extract was partitioned successively between CHCl3 and H2O 
to give CHCl3 extract (30.1 g). The CHCl3 residue was  
fractionated by gradient silica gel column chromatography 
(CC) eluting with a step gradient (0–100% EtOAc in light 
petroleum ether) to yield twelve fractions A–L. Fraction I was 
chromatographed by gradient Si gel CC (light petroleum 
ether/CHCl3, from 9:1 to 3:7, followed by CHCl3/MeOH, from 
9:1 to 8:2) and further purify by Sephadex LH20 (light  
petroleum ether/CHCl3/MeOH, 2:1:1) to give compound 1 (3.2 
mg) and 2 (8.0 mg). 
 
Cipatrijugin G (1): white powder; [α]25D   + 4 (c 0.3, CHCl3); 
IR (KBr) νmax 3442, 2926, 2852, 1742, 1686, 1439, 1379 1250, 
1032 cm–1; 1H and 13C NMR data, see Table 1; ESIMS m/z 
641.2 [M + Na]+; positive ion HRESIMS: m/z 641.2205 (calcd 
for C31H38O13Na, 641.2210). 
 
Cytotoxicity Assay. Compounds 1 and 2 were evaluated for 
their cytotoxicity against human tumor cell line A549 by the 
MTT21 method as previously reported. 
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